CSL BEHRING
Live / Registered — Registered (as of 20 Oct 2026)
What this means for you
Registered since 20 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 97236406
- Registration number
- 8513587
- Mark type
- Stylized text
- Filed
- 25 Jan 2022
- Published for opposition
- 13 Jun 2023
- Registered
- 20 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 20 Oct 2032 (grace period to 20 Apr 2033)
- Attorney of record
- SCOTT D. WOLDOW
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for blood diseases, illnesses and conditions; Pharmaceutical preparations for the treatment or prevention of blood and bleeding disorders; Pharmaceutical preparations for immunology, hematology, respiratory, albumin, transplant, inflammatory, and cardiovascular diseases, illnesses, or conditions; Human blood plasma derived pharmaceutical preparations for the treatment of a wide variety of diseases, illnesses or conditions; pharmaceutical preparations, namely, therapeutic monoclonal and polyclonal antibodies and antibodies for use in the treatment of infectious diseases
Owner
- CSL Behring L.L.C., King of Prussia, PA, US
- CSL Behring L.L.C., King of Prussia, PA, US
- CSL Behring L.L.C., King of Prussia, PA, US
Board proceedings on this mark
- Ex Parte Appeal No. 97236406 — CSL Behring L.L.C., filed 08 May 2023 (Terminated)
The owner also pleads this mark in 4 other Board proceedings.
Prosecution history
- 20 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 29 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Jul 2026 — USE AMENDMENT FILED
- 31 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 03 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2026 — SOU EXTENSION 5 GRANTED
- 07 Jan 2026 — SOU EXTENSION 5 FILED
- 02 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jul 2025 — SOU EXTENSION 4 GRANTED
- 08 Jul 2025 — SOU EXTENSION 4 FILED